Home Gordian Ventures Announces Appointment of Two Senior Executives

Gordian Ventures Announces Appointment of Two Senior Executives

Aug 26, 2022 08:00 CST Updated 08:00
Shanghai, China and Boston, USA, August 26, 2022:Gordian Ventures, a global life sciences venture capital firm, today announced two key appointments to its leadership team:Mr. Josh Jiang (Yifei Jiang) serves as Partner and Chief Financial Officer; and Ms. Andrea Brenner serves as Partner and Chief People Officer.


As a global life sciences incubator, we have experienced management teams in both the United States and China. Geding’s mission is to establish healthcare technology companies with high barriers to entry, collaborating with world-class scientists and entrepreneurs to realize the social value creation of cutting-edge technologies.


2663522751fdc4b35b16ecc13ab79680.png


Ms. Andrea Brenner has over 20 years of experience in the life sciences sector, specializing in building talent pipelines and teams for global pharmaceutical R&D and senior executive roles. She is responsible for all talent relationship management and oversight at Geding Ventures. Previously, she served as Head of Human Resources at several biopharmaceutical companies, including CRISPR Therapeutics, BlueRock Therapeutics (acquired by Bayer), Editas Medicine, Agios Pharmaceuticals, Millennium Pharmaceuticals (acquired by Takeda), and Boston Scientific.


c7016bf584ef527b4352426f13713baf.png


Mr. Jiang Yifei has over 16 years of professional experience in healthcare investment banking, transaction advisory, and financial and tax consulting. Prior to joining Geding Venture Capital, Mr. Jiang served as Managing Director of the Healthcare and Life Sciences Division at China Renaissance, where he successfully completed more than 30 private equity financings, mergers and acquisitions, and initial public offerings (IPOs), with a total transaction value exceeding USD 4 billion. He also served as Head of the China Renaissance Alpha team (early-stage private equity services) and Chief Operating Officer of the Financial Advisory Division. Previously, he worked in the Tax and Business Consulting Department at Deloitte and the Transaction Services practice at PwC, focusing on capital market-related transaction services, as well as financial, tax, and legal services in Asia and Greater China.


>>>>

About Gordian Ventures


Geding Venture Capital is a global life sciences venture capital firm focused on incubating companies with exceptionally high technological barriers.The team at Geding Venture Capital is composed of successful entrepreneurs who are dedicated to becoming true co-founders of every company they operate or incubate.GeDing Venture Capital is headquartered in Boston, with an office in China.